Education
Gbajabiamila donates 484-bed hostel facility to UNILAG
Speaker of the Federal House of Representatives, Abbas Tajudeen, on Wednesday, unveiled a 484-bed hall of residence donated to the University of Lagos by the Chief of Staff to the President, Femi Gbajabiamila.
This was disclosed in a series of tweets and photos shared on the official X handle of the University of Lagos on Wednesday.
According to the posts, the 484-bed space hall of residence is a contribution by Gbajabiamila to the physical infrastructure development of his alma mater.
It read, “The Femi Gbajabiamila Hall of Residence at #UnilagNigeria will be officially commissioned today.
“The 484-bed hostel facility is the landmark contribution of the Chief of Staff to the President, #femigbaja, to the physical infrastructure development of his Alma Mater.

“Our Vice-Chancellor, Prof. Folasade Ogunsola kicks it off on a note of gratitude. She thanks the donor, #femigbaja, for his visionary leadership and large-heartedness.”
The statement further added that while giving his remarks, Gbajabiamila thanked the immediate past VC, Prof. Oluwatoyin Ogundipe for suggesting the hostel as a project idea, and appreciated the current VC, Prof. Ogunsola, for her continuity.
It added that while lauding the donor for his pro-people leadership style, Abbas said, “May this hall of residence be a place where dreams are nurtured to greatness”.
-
Football1 week agoXabi Alonso targets Arda Guler as Chelsea prepare €100m transfer bid
-
Football1 week agoFIFA confirms Jay-Jay Okocha holds World Cup record
-
Business7 days agoDangote cuts petrol, diesel prices again to boost affordability, economic activity
-
Aviation1 week agoInside Airport Luggage Theft: Experts warn of rising insider syndicates
-
Politics1 week agoAmuwo Odofin: Umeadi emerges winner of NDC Reps Primary
-
Featured1 week agoPSG edge Arsenal on penalties to retain Champions League crown
-
Football1 week agoChampions League Final: Talking points ahead of Arsenal vs. PSG match
-
Health4 days agoSenate hearing set to review research on COVID-19 vaccines, cancer concerns

